Serum Amyloid a Protein in the Prediction of Postburn Complications and Fatal Outcome in Patients with Severe Burns

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 1, 1996, Pages 31-36

  Čas, Martin T ^a   Coen, Désirée ^a   Šimić, Diana ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; OROSOMUCOID; SERUM AMYLOID A; SULFADIAZINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BURN; COMPLICATION; CONTROLLED STUDY; FATALITY; HOSPITAL ADMISSION; HUMAN; HYPERMETABOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TOPICAL DRUG ADMINISTRATION;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; BURNS; C-REACTIVE PROTEIN; HUMANS; MIDDLE AGED; OROSOMUCOID; PROGNOSIS; SERUM AMYLOID A PROTEIN;

EID: 0030032076     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.1.31     Document Type: Article

References (19)

1. Arturson MG. The pathophysiology of severe thermal injury J Burn Care Rehab 1985; 6: 129-136.
2. Nijsten MWN., Hack Ce., Helle M., ten Duis HJ., Klasen HJ., Aarden LA. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 1991; 109: 761-767.
3. Chambers RE., Whicher JT., Dieppe PA. Acute phase proteins in inflammatory diseases. Clin Diag Lab 1989; 1: 29-37.
4. Schultz DR., Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, xracid glycoprotein and fibrinogen. Semin Arthritis Rheum 1990; 20: 129-137.
5. Thompson D., MilfordWard A., Whicher JT. The value of acute phase protein measurements in clinical practice. Ann Clin Biodiem 1992; 29: 123-131.
6. Časl MT., SabljarMatovinovic M., Kovaćevic S., Poćanić D., PredenKerekovic V., Jagarinec N. Clinical relevance of serum amyloid A protein monitoring in urinary tract infections. Ann Clin Biochem 1993; 30: 272-277.
7. Časl MT., Rogina B., Glojnarić-Spasić I., Minigo H., PlanincPeraica Y., Jaksic B. The differential diagnostic capacity of serum amyloid A protein between infectious and noninfectious febrile episodes of neutropenic patients with acute leukemia. Leukemia Res 1994; 18: 665-670.
8. Časl MT., Surina B., Glojnarić-Spasić I., Pape E., Jagarinec N., Kranjćević S. Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem 1995; 32: 196-200.
9. Nakayama T., Sonoda S., Urano T., Yamada T., Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases Clin Chem 1993; 39: 293-297.
10. Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sei 1985; 68: 233-238.
11. Tape C., Kisilevsky R. Apolipoprotein Al and serum amyloid A protein halflives during acute inflammation and amyloidogenesis. Biochim Biophys Acta 1990; 1043: 295-300.
12. Feussner G., Ziegler R. Detection of serum amyloid A protein in very low density and high density lipoproteins of patients after acute myocardial infarction. Electrophoresis 1989; 10: 776-780.
13. Parks JS., Rudel LL. Metabolism of the serum amyloid A proteins (SAA) in highdensity lipoproteins and chylomicrons of non human primates (vervet monkey). Am J Pathol 1983; 112: 243-249.
14. Časl MT., Grubb A. A rapid enzymelinked immunosorbent assay (ELISA) for serum amyloid A (SAA) using sequencespecific antibodies. Ann Clin Biochem 1993; 30: 278-286.
15. Grubb A., Lofberg H., Thy sell H., Ljungren L., Olsson T., Skinner M., et al. Production of an amino acid sequencespecific antiserum against human amyloid A (AA) and serum amyloid A (SAA) protein. Scand J Clin Lab Invest 1987; 47: 619-626.
16. Mancini G., Carbonara AO., Heremans JF. Immunochemical quantiation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-254.
17. Maury CPJ., Teppo AM. Comparative study of serum amyloidrelated protein SAA, C-reactive protein, and ²2-microglobulin as markers of renal allograft rejection. Clin Nephrol 1984; 22: 284-292.
18. Časl MT., Bulatović G., Orlić P., Sabljar-Matovinović M. Serum amyloid A protein monitoring for early prediction of kidney allograft rejection Nephron 1995; 70: 112-113.
19. Časl MT., Bulatović G., Orlić P., SabljarMatovinovic M. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection. Nephrol Dial Transplant 1995; 10: 1901-904.